IRONWOOD PHARMACEUTICALS, INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $664.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2021-02-17
- IRONWOOD PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2012-12-31 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2012-09-30 was $127.00K.
- IRONWOOD PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2012-06-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2012-03-31 was $120.00K, a 63.08% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2018 was $664.00K, a 42.31% decline from fiscal 2017.
- IRONWOOD PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2017 was $1.15M, a 81.66% decline from fiscal 2016.
- IRONWOOD PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2016 was $6.28M, a 112.28% increase from fiscal 2015.
- IRONWOOD PHARMACEUTICALS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2015 was $2.96M, a 286.03% increase from fiscal 2014.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2018-12-31 | $664.00K 10-K · filed 2021-02-17 | |||
| 2017-12-31 | $1.15M 10-K · filed 2020-02-13 | |||
| 2016-12-31 | $6.28M 10-K · filed 2019-02-25 | |||
| 2015-12-31 | $2.96M 10-K · filed 2018-02-22 | |||
| 2014-12-31 | $766.00K 10-K · filed 2017-02-22 | |||
| 2013-12-31 | $4.47M 10-K · filed 2016-02-19 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $127.00K derived: sum of 2 quarters · filed 2015-02-18 | $127.00K derived: sum of 3 quarters · filed 2015-02-18 | $247.00K 10-K · filed 2015-02-18 |
| 2012-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $127.00K derived: sum of 2 quarters · filed 2012-11-06 | $247.00K 10-Q · filed 2012-11-06 | $247.00K derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $120.00K 10-Q · filed 2012-08-07 | $120.00K derived: sum of 3 quarters · filed 2014-02-07 | $120.00K derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-03-31 | $120.00K 10-Q · filed 2012-05-10 | $120.00K derived: sum of 2 quarters · filed 2014-02-07 | $120.00K derived: sum of 3 quarters · filed 2014-02-07 | $120.00K derived: sum of 4 quarters · filed 2014-02-07 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $0.00 derived: sum of 2 quarters · filed 2014-02-07 | $0.00 derived: sum of 3 quarters · filed 2014-02-07 | $325.00K 10-K · filed 2014-02-07 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $325.00K 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $325.00K 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $325.00K 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | $529.00K 10-K · filed 2013-02-21 | |||
| 2009-12-31 | $67.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |